Watch: 2024 Advances in Cell Sorting Symposium
2024 Advances in Cell Sorting Symposium
Watch: VisionSort in Imaging and AI Webinar
VisionSort in Imaging and AI Webinar
Advancing Phenotypic Drug Discovery Through Data-Driven Single-Cell Profiling and AI in 2025
Morphology-based classification and isolation of differentiated human iPSCs
VisionSort for Drug Discovery
Watch: VisionSort for Drug Discovery
VisionSort: A New Dimension in Cell Analysis & Sorting
Watch: VisionSort: A New Dimension in Cell Analysis & Sorting (JPN/日本語)
VisionSort: A New Dimension in Cell Analysis & Sorting (JPN/日本語)
Watch: VisionSort: A New Dimension in Cell Analysis & Sorting
VisionSort for Cell Therapy R&D: T-Cells (JPN/日本語)
Watch: VisionSort for Cell Therapy (T-Cell) (JPN/日本語)
VisionSort for Cell Therapy R&D (JPN/日本語)
Watch: VisionSort for Cell Therapy R&D (JPN/日本語)
Pooled compound screening using DNA barcoding and Ghost Cytometry
Watch: VisionSort: Applications in Stem Cell R&D Webinar
VisionSort: Applications in Stem Cell R&D Webinar
Learn more about VisionSort applications in stem cell R&D and regenerative medicine. Highlights include applications in induced pluripotent stem cells (iPSC), human mesenchymal stem cells (hMSC), and progenitor cells. Combining gentle microfluidics based sorting that maintains stem cell viability and differentiation potential with sensitive, label-free isolation of specific cell phenotypes, VisionSort is uniquely positioned to address fundamental challenges in stem cell R&D and regenerative medicine.
Label-free Isolation of Memory-type NK Cells for Cell Therapy R&D
Label-free Morphology-based Identification of T-Helper Cell Subsets
Assessment of Nuclear Morphology in Flow
Gentle Label-Free Sorting of iPSCs with Maintenance of Viability and Quality
Morphology-based Assessment of Viral Load in Mammalian Cells
VisionSort for Phenotypic Drug Screening
Learn more about VisionSort applications in phenotypic drug screening. Providing a perfect complement to existing drug discovery technologies, see how the power of AI and high-resolution morphological profiling come together to enable new phenotypes to screen for and the identification of differentiated hits for discovery campaigns.
Label-free Identification of Proliferative hMSCs
Classification of Mitochondrial Morphology in Activated T cells
Label Free Detection of Subtle Morphological Differences in Immune Cells
Cellular Diversity and Disease Assessment in ALL
Acute Lymphoblastic Leukemia (ALL) is a malignancy of lymphoid progenitor cells in the bone marrow and blood. The disease has a bimodal distribution with 80% of ALL patients presenting as children who respond positively to therapy. However, for adult patients ALL can be a devastating disease, with only 30–40% achieving long–term remission. Chromosomal abnormalities, such as the Philadelphia chromosome, are commonly found in ALL and are a major determinant of prognostic outcome. While long-term survival in pediatric ALL without chromosomal abnormalities approaches 90%, Philadelphia chromosome positive adult ALL has a five-year survival rate of 5 – 20%. As research into the genomic determinants of ALL disease progression and response to […]
Regulatory T cell Characterization and Isolation
Intracellular Phenotyping with Enhanced Spatial Resolution in Flow
B cell Plasma Cell Differentiation
